Ahs Cancer Control Alberta

This early-phase trial tests a one-of-a-kind cell therapy called GCAR1 in a single patient with advanced alveolar soft part sarcoma, a rare cancer that has spread. The therapy uses the patient's own immune cells, modified to recognize and attack cancer cells that carry a specific…

This study tests whether adding niacin (vitamin B3) to standard treatment (radiation and chemotherapy) can help people with newly diagnosed glioblastoma, an aggressive brain cancer. The trial has two phases: first, finding a safe dose of niacin, and second, checking if it improve…

This study tests whether a mobile health program can help adolescents and young adults (ages 15-39) who finished cancer treatment become more physically active. Participants get a personalized activity plan, a fitness tracker, access to an online survivor community, and motivatio…